$NBIS

Neocloud stocks CRWV, NBIS, and IREN fell sharply due to rising concerns over AI infrastructure funding costs and increased credit risk. CoreWeave's CDS spreads exceeded 1,000 basis points. All three companies are expanding but remain unprofitable, with significant debt levels. Analysts rate them as Moderate Buy, with IREN having the highest upside potential.

U.S. stock indexes fell Wednesday after higher-than-expected inflation data raised Fed rate hike concerns. The Nasdaq Composite dropped 1.88%, while the Dow and S&P 500 declined 0.09% and 1.11%, respectively. Semiconductor stocks were hit hard, with Nvidia (NVDA) down 3% and the SOXX ETF falling 4.5%. CoreWeave (CRWV) and Nebius (NBIS) also declined over 15% and 10% respectively, due to a Gartner report on neoclouds. ImmunityBio (IBRX) rose after FDA approval of its drug Anktiva.

Nebius (NBIS) shares fell 9% below $190, testing $180 support, as debt concerns spread across cloud infrastructure stocks. CoreWeave's (CRWV) bond yields surged to 14.5%, signaling higher borrowing costs. Nebius reported 514% cloud revenue growth to $582.3M, but investors focus on $25B capital expenditure and $17.6B liabilities. Technical analysis highlights the 200-day moving average as key support.

Nebius Group (NBIS) fell 3% to $214.99, extending an 11% weekly decline, despite a Buy rating from Rosenblatt. CoreWeave (CRWV) dropped 1% to $80.91. Nebius reported a $37.5B backlog, Q2 2026 revenue of $582.3M, and FY 2026 revenue guidance of $3B-$3.4B. Both companies face market pressures amid high capital expenditures.

Boroditsky Marc (Chief Revenue Officer) sold 7,000 shares of Nebius Group N.V. (NBIS) at $211.23 ($1.48M total) on 2026-10-12 under a Rule 10b5-1 trading plan.

Nebius Group (NBIS) raised prices on its AI-focused cloud computing services, citing strong demand and scarce GPU resources. Q2 2026 revenue surged 454% YoY to $582.3M, with adjusted EBITDA turning positive. However, high capital expenditures and debt led to a net loss, and analysts expect EPS to drop 62.73% in 2027. The stock trades at a premium multiple, reflecting investor bets on future profitability.

Nebius Group NV (NBIS) shares dropped nearly 20% to $210.06 after a bullish chart pattern failed, raising concerns about its rally. The company trades at a high P/S ratio of 42.64, with a GF Score of 52/100, indicating mixed fundamentals. Insiders have sold $316.7 million in shares, while some gurus have increased holdings.

Nebius Group (NBIS) signed a letter of intent to lease computing capacity at VOLT's planned AI gigafactory in Rotterdam. VOLT will build the site and install chips, with Nebius renting the capacity for multiple years. Nebius shares fell 3.51% following the announcement. The first phase of the project is estimated at €7 billion, with construction expected to start in 2028.

Nebius Group (NASDAQ:NBIS) stock fell 4.43% on Monday, extending last week's 8.43% decline amid concerns about AI valuations and infrastructure spending. The drop follows reports of lower-than-expected OpenAI revenue and competition in the AI sector. Nebius raised $2B in Q2, but investors worry about dilution and GPU depreciation. The stock is down from its 20-day and 50-day SMAs but remains above its 200-day SMA.

IREN (IREN) and AST SpaceMobile (ASTS) shares rise 4% on AI and satellite communications developments, while Nebius (NBIS) falls 3% due to market concerns. IREN benefits from Nvidia-related progress and a potential Anthropic deal, with analysts targeting $79.30. ASTS gains from a Deutsche Bank upgrade to Buy, targeting $93. NBIS faces growth-stock valuation pressures despite recent acquisitions and infrastructure deals, with a target of $300.18.